Archive - October 2024
AbbVie Submits Biologics License Application to the FDA for Telisotuzumab Vedotin (Teliso-V) in Previously Treated Non-Small Cell Lung Cancer
Female Pediatricians Earn About 93 Percent of Male Pediatricians
PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients
ED Visit Rate 36.1 per 1,000 Older Adults With Alzheimer Disease
U.S. Food and Drug Administration (FDA) Accepts New Drug Application for Elinzanetant
Stealth BioTherapeutics Announces Positive Vote from FDA Advisory Committee Meeting Supporting Potential Approval of Elamipretide for the Treatment of Barth Syndrome
UroGen Announces FDA Acceptance of its New Drug Application for UGN-102
Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)